Your account is not claimed yet. You can sign up with ORCID to claim your account.

Manik Chatterjee

Years Active: 2019-2020
Publications (10 Years): 2

University Hospital of Würzburg

Charité Universitätsmedizin Berlin (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital of Würzburg Jan 1o 2006

Germany

physician, group leader :: Internal Medicine II, Translational Oncology

Education History

Charité Universitätsmedizin Berlin Apr 15o 1992 - Jul 1o 2000

Germany

PHD :: Medicine

Publications

Horst-Dieter Hummel, Peter Kufer, Carsten Grüllich, Ruth Seggewiss-Bernhardt, Barbara Deschler-Baier, Manik Chatterjee, Maria-Elisabeth Goebeler, Kurt Miller, Maria de Santis, Wolfgang Loidl, Christian Dittrich, Andreas K Buck, Constantin Lapa, Annette Thurner, Sabine Wittemer-Rump, Gökben Koca, Oliver Boix, Wolf-Dietrich Döcke, Ricarda Finnern, Helena Kusi, Antoinette Ajavon-Hartmann, Sabine Stienen, Cyrus Michael Sayehli, Bülent Polat, Ralf Christian Bargou
Pasotuxizumab, a BiTE® immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findings. Immunotherapy 13 (2) (2020)
Daniela Brünnert, Clara Langer, Luise Zimmermann, Ralf Christian Bargou, Martin Burchardt, Manik Chatterjee, Matthias B Stope
The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth. Journal of cellular biochemistry 121 (1) (2019)

Manik Chatterjee.css-eqlu8i{font-size:small;padding-left:4px;}